April 30th 2024
In finalized updates to breast cancer screening recommendations, the United States Preventive Services Task Force (USPSTF) advocates biennial mammography screening for women 40 to 74 years of age and notes insufficient evidence for the use of supplemental MRI in women with dense breasts.
Revolutionizing Early-Stage NSCLC Treatment: Pathologists’ Key Insights into Predicting Pathologic Responses to Immunotherapies
View More
Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs
View More
Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy
View More
23rd Annual International Congress on the Future of Breast Cancer® West
July 12-13, 2024
Register Now!
25th Annual International Lung Cancer Congress®
July 25-27, 2024
Register Now!
2023 ASCO Direct™ Highlights: Practice-Changing Data From the Leading Oncology Conference
View More
6th Annual Precision Medicine Symposium: An Illustrated Tumor Board
October 18-19, 2024
Register Now!
Community Practice Connections™: 24th Annual International Lung Cancer Congress®
View More
FDA Approves Only Closed-Loop Spinal Cord Stimulator to Allow Full-Body 3T MRI
Reportedly the smallest and thinnest implantable spinal cord stimulator (SCS) device, the Inceptiv closed-loop SCS modality allows access to 1.5T and 3T full-body MRI without power restrictions.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
PET/CT Shows Superior Results for Detecting Oligometastatic Breast Cancer in Comparison to CT
In a study of women with oligometastatic breast cancer, the use of 18F-FDG PET/CT detected additional metastases in one-third of cases that were not evident on conventional CT.